The safety and risk management of medical devices are becoming ever more important issues to be addressed by manufacturers. In addition, postmarket surveillance (PMS) and vigilance are very significant elements of risk management. What effect will the review of the Medical Device Directives have on risk management and analysis? Standards change, expectations increase, and information is now more available and transparent. The recent increase in FDA product recalls highlights the necessity to have an established risk management system in place. This interactive seminar will look at the risk management standard, product liability, biological safety, and PMS, and will also provide a detailed practical opportunity to learn the various ways in which a risk analysis may be performed. Understanding how to manage risk is paramount to the success of a medical device company.
Risk Management for Medical Devices
Dec 2nd, 2007Dec 3rd, 2007
London, --
GB
Latest in Home










![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)




